The development and clinical evaluation of second-generation leishmaniasis vaccines
Keywords: ALM, autoclaved L. major; CaVL, canine visceral leishmaniasis; CL, cutaneous leishmaniasis; DAT, direct agglutination test; DCL, diffuse cutaneous leishmaniasis; FAST, fast agglutination screening test; FML, fucose mannose ligand; IFNγ, interferon gamma;